细胞病理学中的关键诊断:大型医疗中心的经验
该研究回顾性分析匹兹堡大学医学中心2011至2016年使用TC66代码的细胞病理报告,共1687份。2015至2016年学术医院65%(30/46)和社区医院10%(46/441)的报告符合机构政策的关键诊断标准,其余多为临床疑似癌症的新发恶性肿瘤诊断。作者认为该代码使用日益增多,不同实践场景使用方式有差异,但确保了及时的患者照护。
要点
- 细胞病理关键诊断代码使用逐年增加,但学术与社区医院符合标准比例差异大。
- 学术医院65%的TC66报告符合关键诊断标准,社区医院仅10%。
- 未符合标准的TC66报告多为临床疑似癌症的新发恶性肿瘤诊断。
核心结论
- 细胞病理关键诊断代码的使用在研究医疗系统中日益增多,学术与社区医院使用方式不同。
- 使用关键诊断代码不仅确保及时患者照护,还提供了可推广的沟通与质量改进模型。
研究设计与样本
- 回顾性审查匹兹堡大学医学中心解剖病理实验室信息系统2011至2016年细胞病理报告。
- 共识别1687份使用TC66代码的细胞病理报告,并进一步审查2015至2016年报告以评估代码使用适当性。
主要发现
- 2015至2016年学术医院46份TC66报告中30份(65%)符合机构政策的关键诊断标准。
- 2015至2016年社区医院441份TC66报告中46份(10%)符合机构政策的关键诊断标准。
- 其余TC66编码病例主要为临床疑似癌症患者的新发恶性肿瘤诊断。
关键数值与推荐
- 符合关键诊断标准比例:学术医院65%(30/46),社区医院10%(46/441)。
临床怎么用
- 细胞病理报告使用关键诊断代码可确保临床团队及时获知并促进患者照护。
- 不同实践场景应关注代码使用的适当性,以优化临床沟通。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critical values have been well established and accepted in laboratory medicine, but to the authors' knowledge are less well accepted in anatomic pathology. Herein, the authors used a reporting process whereby reports with critical diagnoses were coded to ensure that the patient's clinical team was promptly notified electronically of this finding. The aim of the current study was to determine whether this coding mechanism was used appropriately for critical cytopathology diagnoses in the study health care system. METHODS: A retrospective review of the University of Pittsburgh Medical Center anatomic pathology laboratory information system was performed to identify cytopathology reports in which a critical diagnosis code (MedTrak notification/CoPath Tissue Code TC66; TC66) was used from 2011 through 2016. TC66-coded cytopathology reports between 2015 and 2016 were reviewed further to determine whether this code was used appropriately. RESULTS: A total of 1687 TC66-coded cytopathology reports were identified. Between 2015 and 2016, a total of 30 of 46 reports (65%) from academic hospitals and 46 of 441 reports (10%) from community hospitals met the critical diagnoses criteria outlined by institutional policy. The remaining TC66-coded cases were predominantly for new diagnoses of malignancy in patients clinically suspected of having cancer. CONCLUSIONS: Use of a code for critical cytopathology diagnoses was found to be occurring increasingly at the study health care system. Pathologists at the academic and community hospitals in the study institution used this code somewhat differently, reflecting the need to satisfy communication with clinicians in different practice settings. Nevertheless, the authors' experiences with using a code for critical diagnoses not only ensured timely patient care but also proposed a model that could be used by other medical specialties to enhance communication and improve quality of care. Cancer Cytopathol 2017;125:726-30. © 2017 American Cancer Society.
引用
- Xing J, Seigh L, Monaco SE, et al. Critical diagnoses in cytopathology: Experience at a large medical center. Cancer Cytopathol. 2017. PMID: 28704594. doi:10.1002/cncy.21896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。